| Literature DB >> 34880607 |
Teresa Paolucci1, Letizia Pezzi1, Roberta La Verde2, Pasqualino Maietta Latessa3, Rosa Grazia Bellomo4, Raoul Saggini1.
Abstract
BACKGROUND: Aging has been associated with the progressive depletion of lean mass, reductions in muscle strength and the coordination of the lower extremities, accompanied by decreased gait assurance and balance control. Also, less balance control favors falling which is the leading cause of injury among the elderly. The aim of this systematic review is to identify and evaluate existing evidence regarding the use of focused vibration (FV) to improve balance and reduce the risk of falling during the rehabilitation of elderly populations.Entities:
Keywords: equilibrium; exercise; rehabilitation; risk of falls; vibration
Mesh:
Year: 2021 PMID: 34880607 PMCID: PMC8648022 DOI: 10.2147/CIA.S328638
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Figure 1PRISMA flow-diagram indicating the selection of studies included in the review.
Summary of the Studies Included in the Review
| Authors & Year | Diagnosis | n° (M/F); (Mean Age ± SD) | n° TG | Treatment | Outcome Parameters | Evaluation Time | Conclusions |
|---|---|---|---|---|---|---|---|
| Bellomo et al | Sarcopenic elderly | 40 (M); (70.9±5.2) | TG1: 10 | TG1: Global Sensorimotor Training | Maximal force contraction: Maximal isometric test; Balance assessment: sway area of CoP (mm2) | T0: baseline | Maximal force contraction: TG2>TG3>TG1>CG |
| Celletti et al | Elderly women | 350 (F); (73.4±3.11) | TG: 175 | TG: vibratory stimulation | Risk of falling assessment: POMA | T0: baseline | Risk of falling assessment: TG>CG |
| Ehsani et al | Healthy young adults | 30 (12M/18F); | TG1: 10 | TG1, TG2, TG3: vibratory stimulation | Balance assessment: CoG | T0: baseline | Balance assessment: TG1>TG2>TG3 |
| Filippi et al | Sedentary life-style women | 60 (F); (65.3±4.2) | TG1: 20 | TG1: vibratory stimulation contracted muscles | Balance assessment: sway area of CoP (mm2) and velocity | T0: baseline | Balance assessment: TG1>TG2&CG |
| Rabini et al | Men and women >60yrs, with OA | 50 (11M/39F); | TG: 25 | TG: vibratory stimulation | Pain, stiffness, functional limitation assessment: WOMAC | T0: baseline | Pain, stiffness, functional limitation assessment: TG>CG |
| Tankisheva et al | Post- menopausal women | 35 (F); | TG: 17 | TG: Bilateral m. quadriceps, m. gluteus maximus and m. gluteus medius | Muscle strength: isokinetic dynamometry | T0: baseline | Muscle strength: TG>CG |
| Wanderley et al | Women >60yrs, with balance deficit but independent gait | 30 (F); | TG: 15 | TG: vibratory stimulation | Balance assessment: OLS test EO/EC; TUG test; FR test; sway area of CoP (cm2) | T0: baseline | Balance assessment: TG>CG |
| Yu et al | Healthy elderly | 40 (21M/19F); | TG1: 20 | TG1, TG2: vibratory stimulation | Balance assessment: sway area of CoP (cm2) | During treatment (NVO, CVO, TATVO, ATVO; NVT, CVT, TATVT, ATVT) | Balance assessment: in TG1 the ability to balance improves during CVO; in both groups using Combined Vibration decrease CoP sway area. |
Abbreviations: TG, treatment group; CG, control group; OA, Knee Osteoarthritis; CoP, Center of Pressure; OLS test EO/EC, One-leg stance test Eyes open/Eyes closed; TUG test, Time Up-and-Go test; FR test, Functional reach test; POMA, performance-oriented mobility assessment; WOMAC, Western Ontario and McMaster University Osteoarthritis Index; SPPB, Short Physical Performance Battery; CT, Computed Tomography; BMD, Bone Mass Density; DXA, dual-energy X-ray absorptiometry; SWT, Shuttle walk test; mPPT, modified physical performance test; VAS, visual analogic scale; FES-I, short falls efficacy scale-international; STEADI, Stopping Elderly Accidents, Death and Injuries; CoG, center of gravity; NVO, no vibration during one-legged stance; CVO, combined vibration to the Tibialis anterior tendon and Achilles tendon during one-legged stance; TATVO, Tibialis anterior tendon vibration during one-legged stance; ATVO, achilles tendon vibration during one-legged stance; NVT, no vibration during two-legged stance; CVT, combined vibration to the Tibialis anterior tendon and Achilles tendon during two-legged stance; TATVT, Tibialis anterior tendon vibration during two-legged stance; ATVT, achilles tendon vibration during two-legged stance.
Characteristics of Vibration and Parameters Used in the Included Studies
| Authors & Year | Treated Muscles/ Muscles Condition | Duration of One Session | Number of Sessions | Total Number of Sessions | Frequency/ Amplitude | System |
|---|---|---|---|---|---|---|
| Bellomo et al | Bilateral vastus medialis, vastus lateralis and rectus femoris muscles/Relaxed | 15 minutes | 1 session per week for 8 weeks, | 20 | 300 Hz | VISS |
| 3 sessions per week for the last 4 weeks | ||||||
| Celletti et al | Bilateral quadriceps/Contracted | 30 minutes (for every 10 min of vibrations, there was a 1-min interval) | 1 session/day, 3 consecutive days | 3 | 100 Hz/ 0.2–0.5 mm | Cro® System |
| Ehsani et al | Bilateral m. gastrocnemius/Contracted | 1-min warm-up; 30 sec vibratory test; 2-min rest | One day | 8 | 30–40 Hz/ 1±0.002 mm | Focal vibrator attached with Velcro straps to muscle’ belly |
| Filippi et al | TG1: Bilateral quadriceps/Contracted | 30 minutes (for every 10 min of vibrations, there was a 1-min interval) | 1 session/day, 3 consecutive days | 3 | 100 Hz/ 0.2–0.5 mm | Cro® System |
| TG2: Bilateral quadriceps/Relaxed | ||||||
| Rabini et al | Bilateral quadriceps/ Contracted | 30 minutes (for every 10 min of vibrations, there was a 1-min interval) | 1 session/day, 3 consecutive days | 3 | 100 Hz/ 0.2–0.5 mm | Cro® System |
| Tankisheva et al | Bilateral m. quadriceps, m. gluteus maximus and m. gluteus medius/Relaxed | 30 minutes | 5 day per week, consecutive per 6 months | 120 | 25–45 Hz | Powerbox (custom-made vibration design) |
| Wanderley et al | Bilateral Plantar region/ Relaxed | 10 minutes | 12 sessions over 5 weeks, rest period and further 12 sessions over 5 weeks | 24 | 100 Hz/ 2 mm | Novafon SK2c |
| Yu et al | Muscle belly of the Tibialis anterior tendon and/or the Achilles tendon/ Contracted | 5 sec vibratory test, on one or two legs with eyes closed with and without vibration | One day | 8 | 90 Hz/ 0.33mm | JA1 |
The Results Effect of Focused Vibration on Balance and/or Risk of Fall Assessment: Between-Group Differences
| Authors & Year | Outcome Parameters | Results | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bellomo et al | CoP sway area (mm2) | T0 Eyes-open | T0 Eyes-closed | T1 Eyes-open | T1 Eyes-closed | ||||||||||||||||||
| TG1: 7287.8±2402.4 | TG1: 7287.8±2402.4 | TG1: 4436±1884.9 | TG1: 4436±1884.9 | ||||||||||||||||||||
| TG2: 6962.4±1558.05 | TG2: 6962.4±1558.05 | TG2: 6761.2±2301.1 | TG2: 6761.2±2301.1 | ||||||||||||||||||||
| TG3: 7100.2±2920.5 | TG3: 7100.2±2920.5 | TG3: 5927.4±2882.4 | TG3: 5927.4±2882.4 | ||||||||||||||||||||
| CG: 6874.6±2351.3 | CG: 6874.6±2351.3 | CG: 6941.5±1899.5 | CG: 6941.5±1899.5 | ||||||||||||||||||||
| Celletti et al | POMA (point) | T0 | T1 | T2 | |||||||||||||||||||
| TGa:16.1±1.98 | TGa: 22.6±3.44 | TGa: 24.4 ±3.21 | |||||||||||||||||||||
| TGb:21.4±0.83 | TGb: 26.74 ±1.34 | TGb: 27.16±1.84 | |||||||||||||||||||||
| TGc:24.9±0.87 | TGc: 26.07±1.28 | TGc: 27.27±1.43 | |||||||||||||||||||||
| CGa:16.5±1.71 | CGa: ᴓ | CGa: ᴓ | |||||||||||||||||||||
| CGb:21.1±0.83 | CGb: ᴓ | CGb: ᴓ | |||||||||||||||||||||
| CGc:24.6±1.34 | CGc: ᴓ | CGc: ᴓ | |||||||||||||||||||||
| Ehsani et al | CoG sway area (cm2) | T0 Eyes-open | T0 Eyes-closed | T1 Eyes-open 30Hz | T1 Eyes-open 40Hz | T1 Eyes-closed 30Hz | T1 Eyes-open 40Hz | ||||||||||||||||
| TG1: 0.40±0.27 | TG1: 0.65±0.33 | TG1:1.35± 0.99 | TG1:1.29±0.71 | TG1:1.41±0.97 | TG1:1.62±1.18 | ||||||||||||||||||
| TG2: 0.40±0.23 | TG2: 0.54±0.33 | TG2:0.74±0.27 | TG2:0.92±0.40 | TG2:0.93±0.64 | TG2:1.10±0.52 | ||||||||||||||||||
| TG3: 0.58±0.43 | TG3: 1.04±0.59 | TG3:1.15±1.08 | TG3:0.85±0.60 | TG3:1.24±0.60 | TG3:1.52±1.07 | ||||||||||||||||||
| Filippi et al | CoP sway area (mm2) | T0 | T1 | T2 | T3 | ||||||||||||||||||
| TG1: 339±55 | TG1: ᴓ | TG1: ᴓ | TG1: ᴓ | ||||||||||||||||||||
| TG2: 325±59 | TG2: ᴓ | TG2: ᴓ | TG2: ᴓ | ||||||||||||||||||||
| CG: 329±56 | CG: ᴓ | CG: ᴓ | CG: ᴓ | ||||||||||||||||||||
| Rabini et al | POMA (point) | T0 | T1 | T2 | |||||||||||||||||||
| TG:18.60±4.90 | TG:22.56±4.07 | TG:24.36±2.96 | |||||||||||||||||||||
| CG:19.28±4.85 | CG:19.08±3.75 | CG:18.00±4.07 | |||||||||||||||||||||
| Tankisheva et al | mPPT (points), SWT (m) | T0 | T1 | ||||||||||||||||||||
| TG: 33.5 (28–36)†, 317.1 (180–469)† | TG: 40.5±2.12, 313.3±39.4 | ||||||||||||||||||||||
| CG: 32.5 (25–36)†, 307.8 (188–447)† | CG: 32.6±2.87, 322.3±55.0 | ||||||||||||||||||||||
| Wanderley et al | CoP sway area (cm2) | T0 Eyes-open | T0 Eyes-closed | T1 Eyes-open | T1 Eyes-closed | T2 Eyes-open | T2 Eyes-closed | ||||||||||||||||
| TG: 2.95±1.66 | TG: 3.40±1.89 | TG:2.26±1.21 | TG: 2.49±1.61 | TG: 2.23±1.30 | TG:2.28±1.34 | ||||||||||||||||||
| CG: 3.05±2.16 | CG:3.44±2.22 | CG:2.77±2.07 | CG:3.32±2.16 | CG:2.95±1.74 | CG:3.55±1.56 | ||||||||||||||||||
| Yu et al | CoP sway path (mm) | NVO | CVO | TATVO | ATVO | NVT | CVT | TATVT | ATVT | ||||||||||||||
| TG1: 255.51±59.80 | TG1: 191.90±40.67 | TG1: ᴓ | TG1: ᴓ | TG1: 180.51±47.53 | TG1: 124.42±36.78 | TG1: ᴓ | TG1: ᴓ | ||||||||||||||||
| TG2: 220.49±39.75 | TG2: 185.65±29.38 | TG2: ᴓ | TG2: ᴓ | TG2: 150.33±30.57 | TG2: 120.53±22.35 | TG2: ᴓ | TG2: ᴓ | ||||||||||||||||
Notes: Values are expressed as mean ± SD or ranges in parentheses. ᴓIndicated value not detectable, because just graphical. †Indicate range value (minimum and maximum).
Abbreviations: TG, treatment group; CG, control group; a, patient with high risk of falling; b, patient with moderate risk of falling; c, patient with low risk of falling; CoP, Centre of pressure; CoG, Center of gravity; POMA, performance-oriented mobility assessment; SWT, Shuttle walk test; mPPT, modified physical performance test; NVO, No vibration during one-legged stance; CVO, combined vibration to the Tibialis anterior tendon and Achilles tendon during one-legged stance; TATVO, Tibialis anterior tendon vibration during one-legged stance; ATVO, achilles tendon vibration during one-legged stance; NVT, no vibration during two-legged stance; CVT, combined vibration to the Tibialis anterior tendon and Achilles tendon during two-legged stance; TATVT, Tibialis anterior tendon vibration during two-legged stance; ATVT, achilles tendon vibration during two-legged stance.
Level and Methodological Quality of the Evidence of the Included Studies
| Authors & Year | Level of Evidence | Study | Eligibility Criteria* | Random Allocation | Concealed Allocation | Baseline Comparability | Blind Subjects | Blind Therapists | Blind Assessors | More Than 85% Follow-Up | Intention to-Treat Analysis | Between Group Comparisons | Point Estimates and Variability | Total Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bellomo et al | III | RTC | No | Yes | No | No | No | No | Yes | Yes | No | No | Yes | 4/10 |
| Celletti et al | II | RTC | No | Yes | Yes | Yes | No | No | Yes | Yes | No | Yes | Yes | 7/10 |
| Ehsani et al | III | CS | Yes | No | No | No | No | No | No | Yes | Yes | Yes | Yes | 4/10 |
| Filippi et al | II | RTC | Yes | Yes | No | Yes | No | No | Yes | Yes | No | Yes | Yes | 6/10 |
| Rabini et al | II | RTC | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | 9/10 |
| Tankisheva et al | II | RTC | Yes | Yes | No | Yes | No | No | Yes | Yes | No | Yes | Yes | 6/10 |
| Wanderley et al | II | RTC | Yes | Yes | No | Yes | No | No | Yes | Yes | Yes | Yes | Yes | 7/10 |
| Yu et al | III | CSS | Yes | No | No | Yes | No | No | No | Yes | No | Yes | Yes | 4/10 |
Note: *This criteria item does not contribute to total score.
Abbreviations: RTC, randomized trial clinical; CSS, cross-sectional study; CS, clinical study.